Simple pharmaceuticals with short synthesis routes have been made chemically for more than a century, and will be for another.
But there is a class of medicine where chemistry has always struggled — molecules with multiple fused rings, asymmetric centres, reactive side chains. Every step loses yield, every impurity matters, every scale-up is a new problem.
Biology doesn't struggle with any of that. A living cell builds complex molecules in a single, coordinated sequence, calibrated over hundreds of millions of years of evolution.
Our job at NMT is to find the pathway nature uses, install it in a host we can grow reliably, and turn a decade-long chemistry project into a process that fits in one room.